Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Considerations in the development of generic disease therapies for multiple sclerosis.
Infantile metachromatic leukodystrophy in an 18 month old girl.
Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs.
Is pruritus an indicator of aquaporin-positive neuromyelitis optica?
Neurotherapeutic Strategies for Multiple Sclerosis.
Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis.
Neurostatus e-Scoring improves consistency of Expanded Disability Status Scale assessments: A proof of concept study.
How human IgGs against DNA recognize oligonucleotides and DNA.
McDonald Criteria 2010 and 2005 Compared: Persistence of High Oligoclonal Band Prevalence Despite Almost Doubled Diagnostic Sensitivity.
Autonomic function and brain volume.
Multiple sclerosis in Brazil: A systematic review.
Long term sustained therapeutic effects of percutaneous posterior tibial nerve stimulation treatment of neurogenic overactive bladder in multiple sclerosis patients: 12-months results.
Lateral and escalation therapy in relapsing-remitting multiple sclerosis: a comparative study.
Addressing Concerns Regarding the Use of Gadolinium in a Standardized MRI Protocol for the Diagnosis and Follow-Up of Multiple Sclerosis.
Osmotic demyelination syndrome after slow sodium administration in a hyponatremic patient with concurrent hypokalemia.
Allelic variations in rat MHC class II binding of myelin basic protein peptides correlate with encephalitogenicity.
Vaccination with DNA encoding an immunodominant myelin basic protein peptide targeted to Fc of immunoglobulin G suppresses experimental autoimmune encephalomyelitis.
Investigation of flow dynamics of liquid phase in a pilot-scale trickle bed reactor using radiotracer technique.
The urinary-specific quality of life of multiple sclerosis patients: Dutch translation and validation of the SF-Qualiveen.
Adenosine A1-Receptors Modulate mTOR Signaling to Regulate White Matter Inflammatory Lesions Induced by Chronic Cerebral Hypoperfusion.
Therapeutic effect of EDTA in experimental model of multiple sclerosis.
Calcium CaV1 Channel Subtype mRNA Expression in Parkinson's Disease Examined by In Situ Hybridization.
Multifocal enlargement and increased vascularization of peripheral nerves detected by sonography in CIDP: A pilot study.
The best basic science paper on multiple sclerosis in 2012: Commentary.
Telmisartan-mediated metabolic profile conferred brain protection in diabetic hypertensive rats as evidenced by magnetic resonance imaging, behavioral studies and histology.
Pages
« first
‹ previous
…
737
738
739
740
741
742
743
744
745
…
next ›
last »